The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. / Pilgaard, K; Jensen, C; Schou, J; Lyssenko, V; Wegner, L; Brøns, C; Vilsbøll, T; Hansen, T; Madsbad, S; Holst, J; Vølund, A; Poulsen, P; Groop, L; Pedersen, Oluf; Vaag, A; Pilgaard, K; Jensen, C B; Schou, J H; Lyssenko, V; Wegner, L; Brøns, C; Vilsbøll, Tina; Hansen, T; Madsbad, S; Holst, Jens Møller; Vølund, Anders; Poulsen, P; Groop, L; Pedersen, O; Vaag, Allan.
I: Diabetologia, Bind 52, Nr. 7, 01.07.2009, s. 1298-307.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
AU - Pilgaard, K
AU - Jensen, C
AU - Schou, J
AU - Lyssenko, V
AU - Wegner, L
AU - Brøns, C
AU - Vilsbøll, T
AU - Hansen, T
AU - Madsbad, S
AU - Holst, J
AU - Vølund, A
AU - Poulsen, P
AU - Groop, L
AU - Pedersen, Oluf
AU - Vaag, A
AU - Pilgaard, K
AU - Jensen, C B
AU - Schou, J H
AU - Lyssenko, V
AU - Wegner, L
AU - Brøns, C
AU - Vilsbøll, Tina
AU - Hansen, T
AU - Madsbad, S
AU - Holst, Jens Møller
AU - Vølund, Anders
AU - Poulsen, P
AU - Groop, L
AU - Pedersen, O
AU - Vaag, Allan
N1 - Cited By (since 1996): 2Export Date: 4 November 2009Source: Scopus
PY - 2009/7/1
Y1 - 2009/7/1
N2 - AIMS/HYPOTHESIS: We studied the physiological, metabolic and hormonal mechanisms underlying the elevated risk of type 2 diabetes in carriers of TCF7L2 gene. METHODS: We undertook genotyping of 81 healthy young Danish men for rs7903146 of TCF7L2 and carried out various beta cell tests including: 24 h glucose, insulin and glucagon profiles; OGTT; mixed meal test; IVGTT; hyperglycaemic clamp with co-infusion of glucagon-like peptide (GLP)-1 or glucose-dependent insulinotropic polypeptide (GIP); and a euglycaemic-hyperinsulinaemic clamp combined with glucose tracer infusion to study hepatic and peripheral insulin action. RESULTS: Carriers of the T allele were characterised by reduced 24 h insulin concentrations (p < 0.05) and reduced insulin secretion relative to glucose during a mixed meal test (beta index: p < 0.003), but not during an IVGTT. This was further supported by reduced late-phase insulinotropic action of GLP-1 (p = 0.03) and GIP (p = 0.07) during a 7 mmol/l hyperglycaemic clamp. Secretion of GLP-1 and GIP during the mixed meal test was normal. Despite elevated hepatic glucose production, carriers of the T allele had significantly reduced 24 h glucagon concentrations (p < 0.02) suggesting altered alpha cell function. CONCLUSIONS/INTERPRETATION: Elevated hepatic glucose production and reduced insulinotropic effect of incretin hormones contribute to an increased risk of type 2 diabetes in carriers of the rs7903146 risk T allele of TCF7L2.
AB - AIMS/HYPOTHESIS: We studied the physiological, metabolic and hormonal mechanisms underlying the elevated risk of type 2 diabetes in carriers of TCF7L2 gene. METHODS: We undertook genotyping of 81 healthy young Danish men for rs7903146 of TCF7L2 and carried out various beta cell tests including: 24 h glucose, insulin and glucagon profiles; OGTT; mixed meal test; IVGTT; hyperglycaemic clamp with co-infusion of glucagon-like peptide (GLP)-1 or glucose-dependent insulinotropic polypeptide (GIP); and a euglycaemic-hyperinsulinaemic clamp combined with glucose tracer infusion to study hepatic and peripheral insulin action. RESULTS: Carriers of the T allele were characterised by reduced 24 h insulin concentrations (p < 0.05) and reduced insulin secretion relative to glucose during a mixed meal test (beta index: p < 0.003), but not during an IVGTT. This was further supported by reduced late-phase insulinotropic action of GLP-1 (p = 0.03) and GIP (p = 0.07) during a 7 mmol/l hyperglycaemic clamp. Secretion of GLP-1 and GIP during the mixed meal test was normal. Despite elevated hepatic glucose production, carriers of the T allele had significantly reduced 24 h glucagon concentrations (p < 0.02) suggesting altered alpha cell function. CONCLUSIONS/INTERPRETATION: Elevated hepatic glucose production and reduced insulinotropic effect of incretin hormones contribute to an increased risk of type 2 diabetes in carriers of the rs7903146 risk T allele of TCF7L2.
U2 - 10.1007/s00125-009-1307-x
DO - 10.1007/s00125-009-1307-x
M3 - Journal article
C2 - 19288077
VL - 52
SP - 1298
EP - 1307
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - 7
ER -
ID: 11953645